Price $0.62 |
Market Cap
89.9M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.44
|
P/S
23.98
|
Dividend %
-
|
|
P/CF
0.9
|
P/FCF
-
|
Op. Cash Flow
-4K
|
FCF
0.0
|
|
Op. Margin
-173.90%
|
Net Margin
-161.20%
|
ROE
-15.40%
|
ROI
-45.90%
|
|
ROA
-9.80%
|
EPS Growth
59.50%
|
Current Ratio
5.6
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Bausch Health Companies Inc (BHC) | $27.27 | - | - | 10.56B | Strong Buy |
| Concert Pharmaceuticals Inc (CNCE) | $3.71 | - | - | 121M | Strong Buy |
| Cidara Therapeutics Inc (CDTX) | $2.13 | - | - | 107.4M | Strong Buy |
| AngioDynamics, Inc. (ANGO) | $25.31 | - | - | 1.1B | Strong Buy |
| China Pharma Holdings, Inc. (CPHI) | $0.61 | - | - | 30.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
